Pharma Journalist - Page 866 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology

Sanofi and Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810

Braeburn Pharmaceuticals appoints Michael M. Derkacz as President and CEO

ESSA Pharma Presents Data From Phase 1 Trial of EPI-506 at 2017 ASCO Annual Meeting

Kamada Announces Appointment of Michal Stein, M.D., as Vice President and Medical Director

BioCryst Announces RAPIVAB Pediatric sNDA Acceptance

Cornerstone Pharmaceuticals Announces Corporate Name Change to Rafael Pharmaceuticals

Aequus and CDRD to Improve Cannabinoid-based Therapeutics

Jazz Pharmaceuticals Announces FDA Acceptance of NDA for VYXEOS

Sylentis Initiates a Phase III Study for the Treatment of Dry Eye Syndrome